Goldman Sachs Adjusts Price Target on Kenvue to $23 From $21
Is Kenvue Inc. (NYSE:KVUE) The Top Goldman Sachs Fund Manager Stock Pick?
Daily short sale tracking: Ambev SA's short volume increased by 8 million, with a short sale ratio of 19%
Will Kenvue (KVUE) Beat Estimates Again in Its Next Earnings Report?
Kenvue Inc Put Volume Heavy and Directionally Bearish
P/E Ratio Insights for Kenvue
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
US Health Company Kenvue Upgrades Cooperation With Chinese Drugstore Chain
Kenvue's Skin Health & Beauty Segment Likely to Remain Under Pressure, RBC Says
Analysts Agree That Kenvue's Neutrogena Needs a Face-lift
Kenvue Price Target Announced at $24.00/Share by RBC Capital
RBC Capital Downgrades Kenvue(KVUE.US) to Hold Rating, Maintains Target Price $24
Express News | Kenvue Inc : RBC Cuts to Sector Perform From Outperform
Express News | Kenvue Inc : Jefferies Initiates Coverage With Buy Rating; Target Price $27
Kenvue Is Maintained at Neutral by Piper Sandler
Kenvue Analyst Ratings
Citigroup Adjusts Price Target on Kenvue to $23 From $21, Maintains Neutral Rating
Piper Sandler Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)
Express News | Kenvue Drives Climate Action Strategy Forward
Kenvue Inc. (KVUE): A Good Hair Care Stock To Consider Buying Now